Search

Your search keyword '"Gramatzki, Dorothee"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Gramatzki, Dorothee" Remove constraint Author: "Gramatzki, Dorothee" Database Complementary Index Remove constraint Database: Complementary Index
43 results on '"Gramatzki, Dorothee"'

Search Results

1. Glioblastoma in the oldest old: Clinical characteristics, therapy, and outcome in patients aged 80 years and older.

3. Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytoma.

5. A risk model for prediction of diagnosis of cancer after ischemic stroke.

6. Anaplastic ganglioglioma—A diagnosis comprising several distinct tumour types.

8. Association of perioperative adverse events with subsequent therapy and overall survival in patients with WHO grade III and IV gliomas.

9. Venous thromboembolic events in glioblastoma patients: An epidemiological study.

10. Radiotherapy for glioblastoma patients with poor performance status.

12. Survival of brain tumour patients with epilepsy.

13. Cancer is associated with inferior outcome in patients with ischemic stroke.

14. A tumor-promoting role for soluble TβRIII in glioblastoma.

15. Chemotherapy for adult patients with spinal cord gliomas.

16. Endoglin and TGF-β signaling in glioblastoma.

17. Radiomic Analysis to Predict Outcome in Recurrent Glioblastoma Based on Multi-Center MR Imaging From the Prospective DIRECTOR Trial.

18. Antidepressant drug use in glioblastoma patients: an epidemiological view.

19. Synergistic growth inhibition mediated by dual PI3K/mTOR pathway targeting and genetic or direct pharmacological AKT inhibition in human glioblastoma models.

20. End-of-life care for glioma patients; the caregivers' perspective.

21. Bevacizumab versus alkylating chemotherapy in recurrent glioblastoma.

22. Complementary and alternative medicine use in glioma patients in France.

25. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.

27. Management of Elderly Patients with Glioblastoma.

28. Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009.

29. Interleukin-33 in human gliomas: Expression and prognostic significance.

30. Chemotherapy for intracranial ependymoma in adults.

31. Gliomatosis cerebri: no evidence for a separate brain tumor entity.

32. Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups.

33. Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling.

34. Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy.

35. Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation.

36. Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation.

37. Glioma Cell Death Induced by Irradiation or Alkylating Agent Chemotherapy Is Independent of the Intrinsic Ceramide Pathway

39. Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities.

40. Erratum to: Gliomatosis cerebri: no evidence for a separate brain tumor entity.

42. Reply to glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009.

43. MOLECULAR GENETIC DETERMINANTS OF LONG-TERM SURVIVAL WITH GLIOBLASTOMA.

Catalog

Books, media, physical & digital resources